Deep Dive on Digital | pharmaphorum

Deep Dive

Views & Analysis

Responding to dynamic shifts in value communications

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.

Views & Analysis

The tools and techniques making virtual patient simulations ...

Patient simulations have been a key tool for educating physicians in some form for hundreds of years – and now cutting-edge technologies are helping them become more realistic and informati

Views & Analysis

Cutting through the noise for HCPs

In a world producing more content than ever before, getting information to time-poor HCPs can be incredibly difficult – even if they want to find it.

Views & Analysis

Virtual meetings: Where are we now and where are we going?

Pharma has been forced to hold its meetings virtually for most of the year now – but despite having plenty of time to perfect the art of digital engagement, Impetus Digital’s Natalie Yeadon

Views & Analysis

New survey reveals patients’ changing opinions of pharma

Exclusive research from WEGO Health has revealed patients’ changing attitudes towards the pharma industry and how they want to see companies improve.

Digital

Deep Dive: Communications 2020

COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve and expertise varies across the industry.

Responding to dynamic shifts in value communications

The tools and techniques making virtual patient simulations ...

Cutting through the noise for HCPs

Virtual meetings: Where are we now and where are we going?

New survey reveals patients’ changing opinions of pharma

Deep Dive: Communications 2020

Novartis abandons Fabhalta trial in lupus nephritis

Discover a new era of healthcare panel engagement: Grounded ...

Deep Dive

Editor's Picks